Taro Pharmaceutical Industries Analysis
| Analyst Ratings |
|
Average Target Price
|
54.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.84
|
-0.07
|
-0.91
|
-108.33%
|
|
2022-06-30
|
0.85
|
0.37
|
-0.48
|
-56.47%
|
|
2022-03-31
|
0.88
|
0.73
|
-0.15
|
-17.05%
|
|
2021-12-31
|
0.91
|
0.70
|
-0.21
|
-23.08%
|
|
2021-09-30
|
1.02
|
0.62
|
-0.40
|
-39.22%
|
|
2021-06-30
|
0.84
|
-0.50
|
-1.34
|
-159.52%
|
|
2021-03-31
|
0.92
|
-0.78
|
-1.70
|
-184.78%
|
|
2020-12-31
|
1.01
|
0.86
|
-0.15
|
-14.85%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.30
|
|
2022-03-31
|
1.55
|
|
2021-03-31
|
-10.11
|
|
2020-03-31
|
6.36
|
|
2019-03-31
|
7.23
|
|
2018-03-31
|
6.19
|
|
2017-03-31
|
8.47
|
|
2016-03-31
|
0.00
|
|
2015-03-31
|
0.00
|
|
2014-03-31
|
0.02
|
|
2005-03-31
|
0.16
|
|
2004-03-31
|
1.96
|
|
2003-03-31
|
1.65
|
|
2002-03-31
|
1.21
|
|
2001-03-31
|
0.29
|
|
1996-03-31
|
0.22
|
|
1994-03-31
|
0.03
|